Insider Trades189 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 11, 2026 | Sell | EW | Annette Bruls | CVP, EMEACLA | 109 | $92.21 | $49.4B | -10.97% | +18.58% | $10.1K | -0.53% | 16b | Sell Now |
| Jul 10, 2026 | Sell | EW | Daniel J. Lippis | CVP, TAVR | 1,238 | $82.19 | $49.4B | -10.97% | +18.58% | $101.8K | +0.00% | 10b5-1 | Sell Now |
| Jul 7, 2026 | Sell | EW | Daniel J. Lippis | CVP, TAVR | 377 | $95.18 | $49.4B | -10.97% | +18.58% | $35.9K | -0.93% | 16b | Sell Now |
| Jun 30, 2026 | Sell | EW | Daniel J. Lippis | CVP, TAVR | 1,238 | $82.04 | $49.4B | -10.97% | +18.58% | $101.6K | +0.00% | 10b5-1 | Sell Now |
| Jun 17, 2026 | Sell | EW | Bernard J Zovighian | CEO | 523 | $87.92 | $49.4B | -10.97% | +18.58% | $46.0K | -4.34% | 10b5-1 | Sell Now |
| May 29, 2026 | Sell | EW | Andrew M. Dahl | SVP, Corporate Controller | 567.527 | $86.08 | $49.4B | -10.97% | +18.58% | $48.9K | -3.57% | — | Sell Now |
| May 27, 2026 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 23,145 | $86.42 | $49.4B | -10.97% | +18.58% | $2.0M | -19.01% | — | Sell Now |
| May 22, 2026 | Sell | EW | Daveen Chopra | CVP, TMTT & Surgical | 1,500 | $84.60 | $49.4B | -10.97% | +18.58% | $126.9K | -3.27% | — | Sell Now |
| May 18, 2026 | Sell | EW | Daniel J. Lippis | CVP, TAVR | 1,240 | $76.91 | $49.4B | -10.97% | +18.58% | $95.4K | +0.00% | 10b5-1 | Sell Now |
| May 15, 2026 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 17,968 | $81.96 | $49.4B | -10.97% | +18.58% | $1.5M | -25.05% | — | Sell Now |
| May 11, 2026 | Sell | EW | Daniel J. Lippis | CVP, TAVR | 362 | $79.96 | $49.4B | -10.97% | +18.58% | $28.9K | -0.89% | — | Sell Now |
| May 11, 2026 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 7,469 | $79.96 | $49.4B | -10.97% | +18.58% | $597.2K | -18.56% | — | Sell Now |
| May 11, 2026 | Sell | EW | Daveen Chopra | CVP, TMTT & Surgical | 7,538 | $79.96 | $49.4B | -10.97% | +18.58% | $602.7K | -14.13% | — | Sell Now |
| May 11, 2026 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 11,004 | $79.96 | $49.4B | -10.97% | +18.58% | $879.9K | -19.06% | — | Sell Now |
| May 11, 2026 | Sell | EW | Bernard J Zovighian | CEO | 115,829 | $42.54 | $49.4B | -10.97% | +18.58% | $4.9M | -15.82% | 10b5-1 | Sell Now |
| May 8, 2026 | Sell | EW | Annette Bruls | CVP, EMEACLA | 84 | $82.76 | $49.4B | -10.97% | +18.58% | $7.0K | -0.14% | — | Sell Now |
| May 8, 2026 | Sell | EW | Andrew M. Dahl | SVP, Corporate Controller | 289 | $82.76 | $49.4B | -10.97% | +18.58% | $23.9K | -1.26% | — | Sell Now |
| May 7, 2026 | Sell | EW | Daniel J. Lippis | CVP, TAVR | 759 | $82.94 | $49.4B | -10.97% | +18.58% | $63.0K | -0.58% | — | Sell Now |
| May 7, 2026 | Sell | EW | Wayne Markowitz | CVP, JAPAC | 1,083 | $81.21 | $49.4B | -10.97% | +18.58% | $87.9K | -1.09% | — | Sell Now |
| May 7, 2026 | Sell | EW | Daveen Chopra | CVP, TMTT & Surgical | 1,815 | $82.92 | $49.4B | -10.97% | +18.58% | $150.5K | -1.28% | — | Sell Now |
| May 7, 2026 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 1,869 | $82.96 | $49.4B | -10.97% | +18.58% | $155.0K | -1.73% | — | Sell Now |
| May 7, 2026 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 3,034 | $82.96 | $49.4B | -10.97% | +18.58% | $251.7K | -3.77% | — | Sell Now |
| May 7, 2026 | Sell | EW | Bernard J Zovighian | CEO | 28,973 | $27.35 | $49.4B | -10.97% | +18.58% | $792.3K | -1.21% | — | Sell Now |
| May 3, 2026 | Sell | EW | Daveen Chopra | CVP, TMTT & Surgical | 282 | $83.98 | $49.4B | -10.97% | +18.58% | $23.7K | -0.88% | — | Sell Now |
| May 3, 2026 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 469 | $83.98 | $49.4B | -10.97% | +18.58% | $39.4K | -2.21% | — | Sell Now |
| May 3, 2026 | Sell | EW | Bernard J Zovighian | CEO | 1,561 | $27.71 | $49.4B | -10.97% | +18.58% | $43.2K | -0.30% | — | Sell Now |
| May 3, 2026 | Buy | EW | Scott B. Ullem | CVP, Chief Financial Officer | 24,751 | $70.51 | $49.4B | -10.97% | +18.58% | $1.7M | +0.95% | — | Sell Now |
| May 1, 2026 | Sell | EW | Daniel J. Lippis | CVP, TAVR | 4,328 | $72.11 | $49.4B | -10.97% | +18.58% | $312.1K | -0.12% | 10b5-1 | Sell Now |
| Apr 9, 2026 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 26,000 | $69.65 | $49.4B | -10.97% | +18.58% | $1.8M | +0.00% | 10b5-1 | Sell Now |
| Apr 6, 2026 | Sell | EW | Daniel J. Lippis | CVP, TAVR | 2,038 | $70.12 | $49.4B | -10.97% | +18.58% | $142.9K | +0.00% | 10b5-1 | Sell Now |
| Apr 2, 2026 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 45,360 | $69.71 | $49.4B | -10.97% | +18.58% | $3.2M | +0.00% | 10b5-1 | Sell Now |
| Mar 11, 2026 | Sell | EW | Daniel J. Lippis | CVP, TAVR | 2,038 | $72.32 | $49.4B | -10.97% | +18.58% | $147.4K | +0.00% | 10b5-1 | Sell Now |
| Mar 11, 2026 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 26,000 | $72.09 | $49.4B | -10.97% | +18.58% | $1.9M | +0.00% | 10b5-1 | Sell Now |
| Mar 2, 2026 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 22,680 | $72.59 | $49.4B | -10.97% | +18.58% | $1.6M | +0.00% | 10b5-1 | Sell Now |
| Feb 25, 2026 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 24,000 | $83.84 | $49.4B | -10.97% | +18.58% | $2.0M | -53.02% | — | Sell Now |
| Feb 22, 2026 | Sell | EW | Andrew M. Dahl | SVP, Corporate Controller | 176 | $79.78 | $49.4B | -10.97% | +18.58% | $14.0K | -1.90% | — | Sell Now |
| Feb 22, 2026 | Sell | EW | Daniel J. Lippis | CVP, TAVR | 432 | $79.78 | $49.4B | -10.97% | +18.58% | $34.5K | -1.26% | — | Sell Now |
| Feb 16, 2026 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 199 | $75.87 | $49.4B | -10.97% | +18.58% | $15.1K | -0.50% | — | Sell Now |
| Feb 16, 2026 | Sell | EW | Daniel J. Lippis | CVP, TAVR | 456 | $75.87 | $49.4B | -10.97% | +18.58% | $34.6K | -0.66% | — | Sell Now |
| Feb 12, 2026 | Buy | EW | Bernard J Zovighian | CEO | 53,620 | $60.09 | $49.4B | -10.97% | +18.58% | $3.2M | +0.76% | — | Sell Now |
| Jan 9, 2026 | Sell | EW | Daniel J. Lippis | CVP, TAVR | 2,038 | $72.48 | $49.4B | -10.97% | +18.58% | $147.7K | +0.00% | 10b5-1 | Sell Now |
| Jan 6, 2026 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 22,680 | $72.46 | $49.4B | -10.97% | +18.58% | $1.6M | +0.00% | 10b5-1 | Sell Now |
| Dec 12, 2025 | Sell | EW | Daniel J. Lippis | CVP, JAPAC | 2,038 | $71.64 | $49.4B | -10.97% | +18.58% | $146.0K | +0.00% | 10b5-1 | Sell Now |
| Dec 12, 2025 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 18,486.118 | $51.59 | $49.4B | -10.97% | +18.58% | $953.7K | -13.78% | — | Sell Now |
| Dec 11, 2025 | Sell | EW | Daveen Chopra | CVP, TMTT & Surgical | 2,000 | $84.38 | $49.4B | -10.97% | +18.58% | $168.8K | -5.85% | — | Sell Now |
| Dec 10, 2025 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 22,680 | $71.54 | $49.4B | -10.97% | +18.58% | $1.6M | +0.00% | 10b5-1 | Sell Now |
| Dec 9, 2025 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 15,400 | $71.86 | $49.4B | -10.97% | +18.58% | $1.1M | +0.00% | 10b5-1 | Sell Now |
| Dec 8, 2025 | Sell | EW | Wayne Markowitz | CVP, JAPAC | 583 | $86.01 | $49.4B | -10.97% | +18.58% | $50.1K | -3.21% | — | Sell Now |
| Dec 8, 2025 | Sell | EW | Bernard J Zovighian | CEO | 58,426 | $62.57 | $49.4B | -10.97% | +18.58% | $3.7M | +0.00% | 10b5-1 | Sell Now |
| Nov 10, 2025 | Sell | EW | Daniel J. Lippis | CVP, JAPAC | 2,040 | $70.90 | $49.4B | -10.97% | +18.58% | $144.6K | +0.00% | 10b5-1 | Sell Now |
| Nov 10, 2025 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 26,000 | $71.17 | $49.4B | -10.97% | +18.58% | $1.9M | +0.00% | 10b5-1 | Sell Now |
| Sep 14, 2025 | Sell | EW | Wayne Markowitz | CVP, JAPAC | 650 | $77.57 | $49.4B | -10.97% | +18.58% | $50.4K | -3.46% | — | Sell Now |
| Sep 13, 2025 | Sell | EW | Andrew M. Dahl | SVP, Corporate Controller | 262 | $77.57 | $49.4B | -10.97% | +18.58% | $20.3K | -3.20% | — | Sell Now |
| Aug 25, 2025 | Sell | EW | Daveen Chopra | CVP, TMTT | 2,500 | $81.95 | $49.4B | -10.97% | +18.58% | $204.9K | -7.46% | — | Sell Now |
| Aug 18, 2025 | Sell | EW | Larry L Wood | Global President TAVR & Surg | 17,900 | $68.66 | $49.4B | -10.97% | +18.58% | $1.2M | +0.00% | 10b5-1 | Sell Now |
| Jul 28, 2025 | Sell | EW | Daniel J. Lippis | CVP, JAPAC | 4,114 | $79.46 | $49.4B | -10.97% | +18.58% | $326.9K | -15.75% | — | Sell Now |
| Jul 11, 2025 | Sell | EW | Annette Bruls | CVP, EMEACLA | 109 | $78.80 | $49.4B | -10.97% | +18.58% | $8.6K | -0.76% | — | Sell Now |
| Jul 7, 2025 | Sell | EW | Daniel J. Lippis | CVP, JAPAC | 333 | $76.79 | $49.4B | -10.97% | +18.58% | $25.6K | -1.26% | — | Sell Now |
| Jun 16, 2025 | Sell | EW | Larry L Wood | Global President TAVR & Surg | 17,900 | $67.24 | $49.4B | -10.97% | +18.58% | $1.2M | +0.00% | 10b5-1 | Sell Now |
| Jun 2, 2025 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 2,570 | $77.40 | $49.4B | -10.97% | +18.58% | $198.9K | -4.86% | 10b5-1 | Sell Now |
| May 30, 2025 | Sell | EW | Bernard J Zovighian | CEO | 17,066 | $77.22 | $49.4B | -10.97% | +18.58% | $1.3M | -48.45% | 10b5-1 | Sell Now |
| May 22, 2025 | Sell | EW | Daveen Chopra | CVP, TMTT | 1,500 | $75.08 | $49.4B | -10.97% | +18.58% | $112.6K | -4.29% | — | Sell Now |
| May 16, 2025 | Sell | EW | Bernard J Zovighian | CEO | 11,631.102 | $78.00 | $49.4B | -10.97% | +18.58% | $907.2K | +0.00% | — | Sell Now |
| May 11, 2025 | Sell | EW | Daniel J. Lippis | CVP, JAPAC | 271 | $73.68 | $49.4B | -10.97% | +18.58% | $20.0K | -1.02% | — | Sell Now |
| May 11, 2025 | Sell | EW | Daveen Chopra | CVP, TMTT | 580 | $73.68 | $49.4B | -10.97% | +18.58% | $42.7K | -1.63% | — | Sell Now |
| May 11, 2025 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 816 | $73.68 | $49.4B | -10.97% | +18.58% | $60.1K | -1.52% | — | Sell Now |
| May 11, 2025 | Sell | EW | Larry L Wood | Global President TAVR & Surg | 988 | $73.68 | $49.4B | -10.97% | +18.58% | $72.8K | -0.48% | — | Sell Now |
| May 11, 2025 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 1,200 | $73.68 | $49.4B | -10.97% | +18.58% | $88.4K | -2.92% | — | Sell Now |
| May 11, 2025 | Sell | EW | Bernard J Zovighian | CEO | 8,402 | $25.08 | $49.4B | -10.97% | +18.58% | $210.7K | -1.44% | — | Sell Now |
| May 9, 2025 | Sell | EW | Daniel J. Lippis | CVP, JAPAC | 660 | $59.85 | $49.4B | -10.97% | +18.58% | $39.5K | +0.00% | 10b5-1 | Sell Now |
| May 7, 2025 | Sell | EW | Wayne Markowitz | GM & SVP, Surgical | 568 | $74.99 | $49.4B | -10.97% | +18.58% | $42.6K | -1.44% | — | Sell Now |
| May 7, 2025 | Sell | EW | Daveen Chopra | CVP, TMTT | 627 | $74.92 | $49.4B | -10.97% | +18.58% | $47.0K | -0.75% | — | Sell Now |
| May 7, 2025 | Sell | EW | Larry L Wood | Global President TAVR & Surg | 819 | $74.92 | $49.4B | -10.97% | +18.58% | $61.4K | -0.30% | — | Sell Now |
| May 7, 2025 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 851 | $74.92 | $49.4B | -10.97% | +18.58% | $63.8K | -0.84% | — | Sell Now |
| May 7, 2025 | Sell | EW | Bernard J Zovighian | CEO | 12,497 | $25.50 | $49.4B | -10.97% | +18.58% | $318.6K | -0.94% | — | Sell Now |
| May 7, 2025 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 23,906 | $60.73 | $49.4B | -10.97% | +18.58% | $1.5M | -0.67% | 10b5-1 | Sell Now |
| May 3, 2025 | Sell | EW | Daniel J. Lippis | CVP, JAPAC | 472 | $75.65 | $49.4B | -10.97% | +18.58% | $35.7K | -1.04% | — | Sell Now |
| May 3, 2025 | Sell | EW | Daveen Chopra | CVP, TMTT | 580 | $75.65 | $49.4B | -10.97% | +18.58% | $43.9K | -1.06% | — | Sell Now |
| May 3, 2025 | Sell | EW | Larry L Wood | Global President TAVR & Surg | 806 | $75.65 | $49.4B | -10.97% | +18.58% | $61.0K | -0.20% | — | Sell Now |
| May 3, 2025 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 988 | $75.65 | $49.4B | -10.97% | +18.58% | $74.7K | -1.05% | — | Sell Now |
| May 3, 2025 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 1,283 | $75.65 | $49.4B | -10.97% | +18.58% | $97.1K | -2.13% | — | Sell Now |
| May 3, 2025 | Buy | EW | Bernard J Zovighian | CEO | 19,548 | $44.34 | $49.4B | -10.97% | +18.58% | $866.8K | +0.11% | 10b5-1 | Sell Now |
| Apr 14, 2025 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 19,000 | $57.54 | $49.4B | -10.97% | +18.58% | $1.1M | +0.00% | 10b5-1 | Sell Now |
| Apr 8, 2025 | Sell | EW | Daniel J. Lippis | CVP, JAPAC | 600 | $57.94 | $49.4B | -10.97% | +18.58% | $34.8K | +0.00% | 10b5-1 | Sell Now |
| Mar 26, 2025 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 22,500 | $58.07 | $49.4B | -10.97% | +18.58% | $1.3M | +0.00% | 10b5-1 | Sell Now |
| Mar 13, 2025 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 19,000 | $56.62 | $49.4B | -10.97% | +18.58% | $1.1M | +0.00% | 10b5-1 | Sell Now |
| Mar 10, 2025 | Sell | EW | Daniel J. Lippis | CVP, JAPAC | 800 | $57.38 | $49.4B | -10.97% | +18.58% | $45.9K | +0.00% | 10b5-1 | Sell Now |
| Mar 10, 2025 | Buy | EW | Bernard J Zovighian | CEO | 16,225 | $47.23 | $49.4B | -10.97% | +18.58% | $766.3K | +0.63% | 10b5-1 | Sell Now |
| Feb 28, 2025 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 22,500 | $58.03 | $49.4B | -10.97% | +18.58% | $1.3M | +0.00% | 10b5-1 | Sell Now |
| Feb 22, 2025 | Sell | EW | Andrew M. Dahl | SVP, Corporate Controller | 176 | $73.30 | $49.4B | -10.97% | +18.58% | $12.9K | -3.62% | — | Sell Now |
| Feb 16, 2025 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 174 | $76.19 | $49.4B | -10.97% | +18.58% | $13.3K | -0.57% | — | Sell Now |
| Feb 16, 2025 | Sell | EW | Larry L Wood | Global President TAVR & Surg | 333 | $76.19 | $49.4B | -10.97% | +18.58% | $25.4K | -0.17% | — | Sell Now |
| Feb 16, 2025 | Sell | EW | Daniel J. Lippis | CVP, JAPAC | 601 | $76.19 | $49.4B | -10.97% | +18.58% | $45.8K | -0.87% | — | Sell Now |
| Feb 13, 2025 | Sell | EW | Daniel J. Lippis | CVP, JAPAC | 1,000 | $60.81 | $49.4B | -10.97% | +18.58% | $60.8K | +0.00% | 10b5-1 | Sell Now |
| Feb 13, 2025 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 13,000 | $60.51 | $49.4B | -10.97% | +18.58% | $786.7K | +0.00% | 10b5-1 | Sell Now |
| Feb 13, 2025 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 22,500 | $60.52 | $49.4B | -10.97% | +18.58% | $1.4M | +0.00% | 10b5-1 | Sell Now |
| Jan 16, 2025 | Sell | EW | Daniel J. Lippis | CVP, JAPAC | 1,000 | $57.02 | $49.4B | -10.97% | +18.58% | $57.0K | +0.00% | 10b5-1 | Sell Now |
| Jan 16, 2025 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 10,000 | $57.01 | $49.4B | -10.97% | +18.58% | $570.1K | +0.00% | 10b5-1 | Sell Now |
| Dec 16, 2024 | Sell | EW | Daniel J. Lippis | CVP, JAPAC | 5,000 | $59.68 | $49.4B | -10.97% | +18.58% | $298.4K | +0.00% | 10b5-1 | Sell Now |
| Dec 9, 2024 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 10,000 | $58.51 | $49.4B | -10.97% | +18.58% | $585.1K | +0.00% | 10b5-1 | Sell Now |
| Dec 9, 2024 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 22,500 | $58.48 | $49.4B | -10.97% | +18.58% | $1.3M | +0.00% | 10b5-1 | Sell Now |
| Dec 6, 2024 | Sell | EW | Wayne Markowitz | GM & SVP, Surgical | 583 | $73.27 | $49.4B | -10.97% | +18.58% | $42.7K | -5.79% | — | Sell Now |
| Dec 6, 2024 | Sell | EW | Daveen Chopra | CVP, TMTT | 1,750 | $73.27 | $49.4B | -10.97% | +18.58% | $128.2K | -5.97% | — | Sell Now |
| Nov 13, 2024 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 10,000 | $55.42 | $49.4B | -10.97% | +18.58% | $554.2K | +0.00% | 10b5-1 | Sell Now |
| Nov 5, 2024 | Sell | EW | Larry L Wood | Global President TAVR & Surg | 25,000 | $65.91 | $49.4B | -10.97% | +18.58% | $1.6M | -11.18% | 10b5-1 | Sell Now |
| Oct 15, 2024 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 10,000 | $57.39 | $49.4B | -10.97% | +18.58% | $573.9K | +0.00% | 10b5-1 | Sell Now |
| Sep 14, 2024 | Sell | EW | Wayne Markowitz | GM & SVP, Surgical | 648 | $68.52 | $49.4B | -10.97% | +18.58% | $44.4K | -6.07% | — | Sell Now |
| Sep 11, 2024 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 10,000 | $56.02 | $49.4B | -10.97% | +18.58% | $560.2K | +0.00% | 10b5-1 | Sell Now |
| Sep 3, 2024 | Sell | EW | Catherine M. Szyman | CVP, Critical Care | 5,530 | $69.96 | $49.4B | -10.97% | +18.58% | $386.9K | -6.37% | — | Sell Now |
| Aug 20, 2024 | Sell | EW | Daveen Chopra | CVP, TMTT | 1,250 | $69.95 | $49.4B | -10.97% | +18.58% | $87.4K | -4.09% | — | Sell Now |
| Aug 14, 2024 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 10,000 | $55.68 | $49.4B | -10.97% | +18.58% | $556.8K | +0.00% | 10b5-1 | Sell Now |
| Jul 11, 2024 | Sell | EW | Daniel J. Lippis | CVP, JAPAC | 1,000 | $69.73 | $49.4B | -10.97% | +18.58% | $69.7K | +0.00% | 10b5-1 | Sell Now |
| Jul 10, 2024 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 10,000 | $69.29 | $49.4B | -10.97% | +18.58% | $692.9K | +0.00% | 10b5-1 | Sell Now |
| Jul 7, 2024 | Sell | EW | Jean-Luc M Lemercier | CVP, EMEACLA and JAPAC | 82 | $92.32 | $49.4B | -10.97% | +18.58% | $7.6K | -0.04% | — | Sell Now |
| Jul 7, 2024 | Sell | EW | Catherine M. Szyman | CVP, Critical Care | 258 | $92.32 | $49.4B | -10.97% | +18.58% | $23.8K | -0.34% | — | Sell Now |
| Jul 7, 2024 | Sell | EW | Daniel J. Lippis | CVP, JAPAC | 410 | $92.32 | $49.4B | -10.97% | +18.58% | $37.9K | -1.74% | — | Sell Now |
| Jun 20, 2024 | Sell | EW | Daniel J. Lippis | CVP, JAPAC | 1,070 | $67.64 | $49.4B | -10.97% | +18.58% | $72.4K | +0.00% | 10b5-1 | Sell Now |
| Jun 20, 2024 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 11,250 | $66.39 | $49.4B | -10.97% | +18.58% | $746.9K | +0.00% | 10b5-1 | Sell Now |
| Jun 12, 2024 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 10,000 | $66.41 | $49.4B | -10.97% | +18.58% | $664.1K | +0.00% | 10b5-1 | Sell Now |
| May 30, 2024 | Sell | EW | Bernard J Zovighian | CEO | 8,617 | $87.68 | $49.4B | -10.97% | +18.58% | $755.5K | -11.21% | 10b5-1 | Sell Now |
| May 21, 2024 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 11,250 | $67.87 | $49.4B | -10.97% | +18.58% | $763.5K | +0.00% | 10b5-1 | Sell Now |
| May 11, 2024 | Sell | EW | Jean-Luc M Lemercier | CVP, EMEACLA and JAPAC | 21 | $86.72 | $49.4B | -10.97% | +18.58% | $1.8K | -0.01% | — | Sell Now |
| May 11, 2024 | Sell | EW | Robert W.A. Sellers | SVP, Corporate Controller | 229 | $86.72 | $49.4B | -10.97% | +18.58% | $19.9K | -1.32% | — | Sell Now |
| May 11, 2024 | Sell | EW | Daniel J. Lippis | CVP, JAPAC | 377 | $86.72 | $49.4B | -10.97% | +18.58% | $32.7K | -1.58% | — | Sell Now |
| May 11, 2024 | Sell | EW | Daveen Chopra | CVP, TMTT | 821 | $86.72 | $49.4B | -10.97% | +18.58% | $71.2K | -2.61% | — | Sell Now |
| May 11, 2024 | Sell | EW | Catherine M. Szyman | CVP, Critical Care | 827 | $86.72 | $49.4B | -10.97% | +18.58% | $71.7K | -1.07% | — | Sell Now |
| May 11, 2024 | Sell | EW | Larry L Wood | Global President TAVR & Surg | 985 | $86.72 | $49.4B | -10.97% | +18.58% | $85.4K | -0.44% | — | Sell Now |
| May 11, 2024 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 1,198 | $86.72 | $49.4B | -10.97% | +18.58% | $103.9K | -3.77% | — | Sell Now |
| May 11, 2024 | Sell | EW | Bernard J Zovighian | CEO | 2,854 | $86.72 | $49.4B | -10.97% | +18.58% | $247.5K | -3.58% | — | Sell Now |
| May 10, 2024 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 10,814 | $68.06 | $49.4B | -10.97% | +18.58% | $736.0K | -0.38% | 10b5-1 | Sell Now |
| May 7, 2024 | Sell | EW | Jean-Luc M Lemercier | CVP, EMEACLA and JAPAC | 46 | $85.09 | $49.4B | -10.97% | +18.58% | $3.9K | -0.02% | — | Sell Now |
| May 7, 2024 | Sell | EW | Robert W.A. Sellers | SVP, Corporate Controller | 178 | $85.09 | $49.4B | -10.97% | +18.58% | $15.1K | -0.80% | — | Sell Now |
| May 7, 2024 | Sell | EW | Daveen Chopra | CVP, TMTT | 447 | $85.09 | $49.4B | -10.97% | +18.58% | $38.0K | -0.59% | — | Sell Now |
| May 7, 2024 | Sell | EW | Catherine M. Szyman | CVP, Critical Care | 609 | $85.09 | $49.4B | -10.97% | +18.58% | $51.8K | -0.78% | — | Sell Now |
| May 7, 2024 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 619 | $85.09 | $49.4B | -10.97% | +18.58% | $52.7K | -0.65% | — | Sell Now |
| May 7, 2024 | Sell | EW | Bernard J Zovighian | CEO | 647 | $85.09 | $49.4B | -10.97% | +18.58% | $55.1K | -0.22% | — | Sell Now |
| May 7, 2024 | Sell | EW | Larry L Wood | Global President TAVR & Surg | 695 | $85.09 | $49.4B | -10.97% | +18.58% | $59.1K | -0.24% | — | Sell Now |
| May 7, 2024 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 790 | $85.09 | $49.4B | -10.97% | +18.58% | $67.2K | -0.72% | — | Sell Now |
| May 7, 2024 | Sell | EW | Daniel J. Lippis | CVP, JAPAC | 2,300 | $67.27 | $49.4B | -10.97% | +18.58% | $154.7K | -0.63% | 10b5-1 | Sell Now |
| May 3, 2024 | Sell | EW | Robert W.A. Sellers | SVP, Corporate Controller | 226 | $85.16 | $49.4B | -10.97% | +18.58% | $19.2K | -0.74% | — | Sell Now |
| May 3, 2024 | Sell | EW | Jean-Luc M Lemercier | CVP, EMEACLA and JAPAC | 296 | $85.23 | $49.4B | -10.97% | +18.58% | $25.2K | -0.08% | — | Sell Now |
| May 3, 2024 | Sell | EW | Daniel J. Lippis | CVP, JAPAC | 572 | $85.16 | $49.4B | -10.97% | +18.58% | $48.7K | -1.65% | — | Sell Now |
| May 3, 2024 | Sell | EW | Daveen Chopra | CVP, TMTT | 2,612 | $85.23 | $49.4B | -10.97% | +18.58% | $222.6K | -5.23% | — | Sell Now |
| May 3, 2024 | Sell | EW | Catherine M. Szyman | CVP, Critical Care | 3,921 | $85.23 | $49.4B | -10.97% | +18.58% | $334.2K | -4.23% | — | Sell Now |
| May 3, 2024 | Sell | EW | Larry L Wood | Global President TAVR & Surg | 3,936 | $85.23 | $49.4B | -10.97% | +18.58% | $335.5K | -0.91% | — | Sell Now |
| May 3, 2024 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 3,954 | $85.23 | $49.4B | -10.97% | +18.58% | $337.0K | -4.66% | — | Sell Now |
| May 3, 2024 | Sell | EW | Bernard J Zovighian | CEO | 4,825.26 | $85.29 | $49.4B | -10.97% | +18.58% | $411.5K | -3.74% | — | Sell Now |
| May 3, 2024 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 5,065 | $85.23 | $49.4B | -10.97% | +18.58% | $431.7K | -11.26% | — | Sell Now |
| May 1, 2024 | Sell | EW | Jean-Luc M Lemercier | CVP, EMEACLA and JAPAC | 28,800 | $60.48 | $49.4B | -10.97% | +18.58% | $1.7M | +0.00% | 10b5-1 | Sell Now |
| Apr 30, 2024 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 14,500 | $61.28 | $49.4B | -10.97% | +18.58% | $888.5K | +0.00% | 10b5-1 | Sell Now |
| Apr 9, 2024 | Sell | EW | Daniel J. Lippis | CVP, JAPAC | 1,714 | $64.55 | $49.4B | -10.97% | +18.58% | $110.6K | +0.00% | 10b5-1 | Sell Now |
| Apr 8, 2024 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 25,000 | $64.54 | $49.4B | -10.97% | +18.58% | $1.6M | +0.00% | 10b5-1 | Sell Now |
| Apr 8, 2024 | Sell | EW | Jean-Luc M Lemercier | CVP, EMEACLA | 28,800 | $64.54 | $49.4B | -10.97% | +18.58% | $1.9M | +0.00% | 10b5-1 | Sell Now |
| Apr 1, 2024 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 14,510 | $65.82 | $49.4B | -10.97% | +18.58% | $955.0K | +0.00% | 10b5-1 | Sell Now |
| Mar 13, 2024 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 29,000 | $63.88 | $49.4B | -10.97% | +18.58% | $1.9M | +0.00% | 10b5-1 | Sell Now |
| Mar 11, 2024 | Sell | EW | Jean-Luc M Lemercier | CVP, EMEACLA and JAPAC | 28,800 | $64.21 | $49.4B | -10.97% | +18.58% | $1.8M | +0.00% | 10b5-1 | Sell Now |
| Mar 7, 2024 | Sell | EW | Daniel J. Lippis | CVP, JAPAC | 3,430 | $63.87 | $49.4B | -10.97% | +18.58% | $219.1K | +0.00% | 10b5-1 | Sell Now |
| Feb 29, 2024 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 14,510 | $61.17 | $49.4B | -10.97% | +18.58% | $887.5K | +0.00% | 10b5-1 | Sell Now |
| Feb 21, 2024 | Sell | EW | Daveen Chopra | CVP, TMTT | 15,200 | $74.08 | $49.4B | -10.97% | +18.58% | $1.1M | -1.42% | — | Sell Now |
| Feb 16, 2024 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 174 | $86.04 | $49.4B | -10.97% | +18.58% | $15.0K | -0.90% | — | Sell Now |
| Feb 16, 2024 | Sell | EW | Larry L Wood | Global President TAVR & Surg | 317 | $86.04 | $49.4B | -10.97% | +18.58% | $27.3K | -0.15% | — | Sell Now |
| Feb 16, 2024 | Sell | EW | Daniel J. Lippis | CVP, JAPAC | 545 | $86.08 | $49.4B | -10.97% | +18.58% | $46.9K | -1.03% | — | Sell Now |
| Feb 13, 2024 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 22,000 | $61.29 | $49.4B | -10.97% | +18.58% | $1.3M | +0.00% | 10b5-1 | Sell Now |
| Feb 13, 2024 | Sell | EW | Catherine M. Szyman | CVP, Critical Care | 94,000 | $61.36 | $49.4B | -10.97% | +18.58% | $5.8M | +0.00% | — | Sell Now |
| Feb 12, 2024 | Sell | EW | Robert W.A. Sellers | SVP, Corporate Controller | 24,420 | $61.88 | $49.4B | -10.97% | +18.58% | $1.5M | +0.00% | — | Sell Now |
| Feb 1, 2024 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 14,510 | $57.52 | $49.4B | -10.97% | +18.58% | $834.6K | +0.00% | 10b5-1 | Sell Now |
| Jan 12, 2024 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 20,000 | $56.21 | $49.4B | -10.97% | +18.58% | $1.1M | +0.00% | 10b5-1 | Sell Now |
| Dec 29, 2023 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 29,020 | $56.65 | $49.4B | -10.97% | +18.58% | $1.6M | +0.00% | 10b5-1 | Sell Now |
| Dec 15, 2023 | Sell | EW | Daveen Chopra | CVP, TMTT | 14,000 | $68.75 | $49.4B | -10.97% | +18.58% | $962.5K | +0.00% | — | Sell Now |
| Dec 13, 2023 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 16,000 | $54.30 | $49.4B | -10.97% | +18.58% | $868.9K | +0.00% | 10b5-1 | Sell Now |
| Dec 13, 2023 | Sell | EW | Larry L Wood | Global President TAVR & Surg | 17,316 | $58.57 | $49.4B | -10.97% | +18.58% | $1.0M | +0.00% | 10b5-1 | Sell Now |
| Dec 6, 2023 | Sell | EW | Daveen Chopra | CVP, TMTT | 7,000 | $64.63 | $49.4B | -10.97% | +18.58% | $452.4K | +0.00% | 10b5-1 | Sell Now |
| Nov 13, 2023 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 12,000 | $51.02 | $49.4B | -10.97% | +18.58% | $612.3K | +0.00% | 10b5-1 | Sell Now |
| Nov 13, 2023 | Sell | EW | Larry L Wood | Global President TAVR & Surg | 17,320 | $55.29 | $49.4B | -10.97% | +18.58% | $957.6K | +0.00% | 10b5-1 | Sell Now |
| Oct 31, 2023 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 14,510 | $49.70 | $49.4B | -10.97% | +18.58% | $721.2K | +0.00% | 10b5-1 | Sell Now |
| Oct 13, 2023 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 10,000 | $53.37 | $49.4B | -10.97% | +18.58% | $533.7K | +0.00% | 10b5-1 | Sell Now |
| Oct 13, 2023 | Sell | EW | Larry L Wood | Global President TAVR & Surg | 17,320 | $57.64 | $49.4B | -10.97% | +18.58% | $998.3K | +0.00% | 10b5-1 | Sell Now |
| Oct 10, 2023 | Sell | EW | Catherine M. Szyman | CVP, Critical Care | 10,000 | $54.72 | $49.4B | -10.97% | +18.58% | $547.1K | +0.00% | 10b5-1 | Sell Now |
| Oct 3, 2023 | Sell | EW | Daveen Chopra | CVP, TMTT | 17,000 | $64.63 | $49.4B | -10.97% | +18.58% | $1.1M | +0.00% | 10b5-1 | Sell Now |
| Sep 29, 2023 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 14,510 | $53.15 | $49.4B | -10.97% | +18.58% | $771.1K | +0.00% | 10b5-1 | Sell Now |
| Sep 14, 2023 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 9,000 | $55.23 | $49.4B | -10.97% | +18.58% | $497.1K | +0.00% | 10b5-1 | Sell Now |
| Sep 14, 2023 | Sell | EW | Larry L Wood | Global President TAVR & Surg | 17,320 | $59.45 | $49.4B | -10.97% | +18.58% | $1.0M | +0.00% | 10b5-1 | Sell Now |
| Sep 8, 2023 | Sell | EW | Catherine M. Szyman | CVP, Critical Care | 10,000 | $56.38 | $49.4B | -10.97% | +18.58% | $563.8K | +0.00% | 10b5-1 | Sell Now |
| Sep 6, 2023 | Sell | EW | Daveen Chopra | CVP, TMTT | 17,000 | $67.66 | $49.4B | -10.97% | +18.58% | $1.2M | +0.00% | 10b5-1 | Sell Now |
| Aug 31, 2023 | Sell | EW | Scott B. Ullem | CVP, Chief Financial Officer | 14,510 | $57.27 | $49.4B | -10.97% | +18.58% | $831.0K | +0.00% | 10b5-1 | Sell Now |
| Aug 29, 2023 | Sell | EW | Daveen Chopra | CVP, TMTT | 1,500 | $76.69 | $49.4B | -10.97% | +18.58% | $115.0K | -5.89% | — | Sell Now |
| Aug 14, 2023 | Sell | EW | Donald E Jr Bobo | CVP,Strategy/Corp Development | 9,000 | $58.02 | $49.4B | -10.97% | +18.58% | $522.2K | +0.00% | 10b5-1 | Sell Now |
| Aug 14, 2023 | Sell | EW | Larry L Wood | Global President TAVR & Surg | 12,842 | $62.29 | $49.4B | -10.97% | +18.58% | $799.9K | +0.00% | 10b5-1 | Sell Now |
| Aug 9, 2023 | Sell | EW | Catherine M. Szyman | CVP, Critical Care | 10,000 | $57.69 | $49.4B | -10.97% | +18.58% | $576.9K | +0.00% | 10b5-1 | Sell Now |